Acadian Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Buy |
|
|||||
|
2025
Q1 | $284K | Buy |
|
|||||
|
2024
Q4 | $364K | Sell |
|
|||||
|
2024
Q3 | $872K | Sell |
|
|||||
|
2024
Q2 | $1.62M | Buy |
|
|||||
|
2024
Q1 | $933K | Sell |
|
|||||
|
2023
Q4 | $2.48M | Sell |
|
|||||
|
2023
Q3 | $5.34M | Buy |
|
|||||
|
2023
Q2 | $2.87M | Buy |
|
|||||
|
2023
Q1 | $391K | Sell |
|
|||||
|
2022
Q4 | $2.89M | Sell |
|
|||||
|
2022
Q3 | $6.09M | Buy |
|
|||||
|
2022
Q2 | $5.6M | Sell |
|
|||||
|
2022
Q1 | $9.54M | Sell |
|
|||||
|
2021
Q4 | $13M | Sell |
|
|||||
|
2021
Q3 | $33.9M | Buy |
|
|||||
|
2021
Q2 | $19.2M | Buy |
|
|||||
|
2021
Q1 | $14.7M | Sell |
|
|||||
|
2020
Q4 | $29.2M | Sell |
|
|||||
|
2020
Q3 | $45.8M | Buy |
|
|||||
|
2020
Q2 | $34.1M | Buy |
|
|||||
|
2020
Q1 | $19.7M | Buy |
|
|||||
|
2019
Q4 | $2.13M | Buy |
|
|||||
|
2019
Q3 | $401K | Sell |
|
|||||
|
2019
Q2 | $429K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $2K | Sell |
|
|||||
|
2016
Q3 | $875K | Buy |
|
|||||
|
2016
Q2 | $12K | Buy |
|
|||||
|
2016
Q1 | $2K | Sell |
|
|||||
|
2015
Q4 | $3K | Sell |
|
|||||
|
2015
Q3 | $5K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $1.33M | Buy |
|
|||||
|
2013
Q3 | $221K | Buy |
|